Clinical Trial

Effect of Honey For CIN II

Study acronym: HoneyForCINII
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The following hypothesis is tested: Medical grade honey in CIN II causes a higher clearance of the hr-HPV virus and an increase in the normalization of CIN II lesions compared to expectant management.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-01-11; most recent amendment 2025-06-13.
Status change: Not Yet Recruiting → Recruiting 2025-02-10
Trial Details
NCT Number NCT06219018
Lead Sponsor Zuyderland Medisch Centrum
Conditions Cervical Intraepithelial Neoplasia-II, High Risk Human Papillomavirus
Enrollment 60 participants
Start Date 2024-12-30
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-18